Literature DB >> 9697264

Laparoscopic cholecystectomy: a report on the community hospital experience in Hokkaido.

N Kurauchi1, N Kamii, K Kazui, Y Saji, J Uchino.   

Abstract

We analyzed the outcome of 1408 patients who underwent laparoscopic cholecystectomy (LC) between February 1991 and October 1993 in affiliated community hospitals around Hokkaido, Japan. LC was performed for symptomatic gallstones (68%) and asymptomatic gallstones (29%) using the pneumoperitoneum (96%) or abdominal wall lift (4%) techniques. Intraoperative and postoperative complications occurred in 105 patients (10%), including bile duct injuries in 9 patients (0.9%). Conversion to open surgery or reoperation was required in 89 patients (8%) mainly because of unclear anatomy, difficulties with hemostasis, or bile duct injury. One patient died of congestive heart failure, resulting in a mortality rate of 0.07%. The patients were discharged after an average of 8 days, and returned to work after an average of 14 days. The complication and conversion rates were high; however, the incidences of reoperation, bile duct injuries, postoperative bile leaks, and deaths were low. In conclusion, LC was performed with acceptable safety in our community hospitals. The reason for this is most likely that conventional cholecystectomy was preferred to LC in difficult cases during this early period.

Entities:  

Mesh:

Year:  1998        PMID: 9697264     DOI: 10.1007/BF02484617

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  24 in total

1.  Laparoscopic cholecystectomy: an approach without pneumoperitoneum.

Authors:  D Hashimoto; S A Nayeem; S Kajiwara; T Hoshino
Journal:  Surg Endosc       Date:  1993 Jan-Feb       Impact factor: 4.584

2.  Early experience with minimally invasive surgery: a New Zealand audit.

Authors:  J A Windsor; D E Vokes
Journal:  Aust N Z J Surg       Date:  1994-02

3.  Current status of conventional (open) cholecystectomy versus laparoscopic cholecystectomy.

Authors:  J L Sawyers
Journal:  Ann Surg       Date:  1996-01       Impact factor: 12.969

Review 4.  National Institutes of Health Consensus Development Conference Statement on Gallstones and Laparoscopic Cholecystectomy.

Authors: 
Journal:  Am J Surg       Date:  1993-04       Impact factor: 2.565

5.  Conversions and complications of laparoscopic cholecystectomy. Results of a survey conducted by the French Society of Endoscopic Surgery and Interventional Radiology.

Authors:  D Collet; M Edye; J Périssat
Journal:  Surg Endosc       Date:  1993 Jul-Aug       Impact factor: 4.584

6.  Mechanisms of major biliary injury during laparoscopic cholecystectomy.

Authors:  A M Davidoff; T N Pappas; E A Murray; D J Hilleren; R D Johnson; M E Baker; G E Newman; P B Cotton; W C Meyers
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

7.  Multipractice analysis of laparoscopic cholecystectomy in 1,983 patients.

Authors:  G M Larson; G C Vitale; J Casey; J S Evans; G Gilliam; L Heuser; G McGee; M Rao; M J Scherm; C R Voyles
Journal:  Am J Surg       Date:  1992-02       Impact factor: 2.565

8.  An early review of 800 laparoscopic cholecystectomies at a university-affiliated community teaching hospital.

Authors:  D R Baird; J P Wilson; E M Mason; T D Duncan; J S Evans; J P Luke; D M Ruben; G W Lucas
Journal:  Am Surg       Date:  1992-03       Impact factor: 0.688

9.  Laparoscopic versus minilaparotomy cholecystectomy: a randomised trial.

Authors:  A J McMahon; I T Russell; J N Baxter; S Ross; J R Anderson; C G Morran; G Sunderland; D Galloway; G Ramsay; P J O'Dwyer
Journal:  Lancet       Date:  1994-01-15       Impact factor: 79.321

10.  The early experience with laparoscopic cholecystectomy in Oregon.

Authors:  K E Deveney
Journal:  Arch Surg       Date:  1993-06
View more
  1 in total

Review 1.  Common uses and cited complications of energy in surgery.

Authors:  Ganesh Sankaranarayanan; Rajeswara R Resapu; Daniel B Jones; Steven Schwaitzberg; Suvranu De
Journal:  Surg Endosc       Date:  2013-04-23       Impact factor: 4.584

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.